SC-403

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameSC-403
Drug Alias NameSC403
ClassificationOther
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsShort Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSancilio & Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSancilio & Company Inc
Active IndicationsN/A
Inactive IndicationsShort Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A